XML 21 R10.htm IDEA: XBRL DOCUMENT

Note 4 - Other Financial Information

9 Months Ended

Sep. 30, 2022

Note 4 – Other Financial Information

Accounts Payable and Accrued Expenses

Accounts payable and accrued expenses consisted of the following as of September 30, 2022 and December 31, 2021 (in thousands):

	*September 30,*		*December 31,*
	*2022*		*2021*
Accounts payable	$	2,545	$	5,786
Accrued sales reserves		687		497
Accrued clinical expenses		2,285		1,377
Accrued research and development expenses		1,118		1,748
Accrued selling, general and administrative expenses		2,139		1,965
Accrued other expenses		582		729
Total accounts payable and accrued expenses	$	9,356	$	12,102

Interest and Other Income, Net

Interest and other income, net consisted of the following as of September 30, 2022 and 2021 (in thousands):

	*Nine Months Ended September 30,*
	*2022*		*2021*
Interest income	$	469	$	345
Other income (expense), net		135		(76	)
Interest and other income, net	$	604	$	269